{"id":16092,"date":"2021-06-15T12:24:17","date_gmt":"2021-06-15T10:24:17","guid":{"rendered":"http:\/\/miunidad.eu\/porib.com\/?p=16092"},"modified":"2022-04-29T12:30:03","modified_gmt":"2022-04-29T10:30:03","slug":"tratamiento-para-leucemia-mieloide-aguda-mas-eficiente-para-el-sns","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/tratamiento-para-leucemia-mieloide-aguda-mas-eficiente-para-el-sns\/","title":{"rendered":"Tratamiento para Leucemia Mieloide Aguda m\u00e1s eficiente para el SNS"},"content":{"rendered":"<p>De acuerdo con\u00a0los resultados presentados en el art\u00edculo:\u00a0<em><strong>Cost-effectiveness analysis of gemtuzumab ozogamicin for first-line treatment of patients with CD-33 positive acute myeloid leukaemia in Spain<\/strong><\/em>, el tratamiento con gemtuzumab ozogamicina (GO) + quimioterapia habitual (SOC)\u00a0podr\u00eda ser una opci\u00f3n m\u00e1s eficiente para el tratamiento en primera l\u00ednea en pacientes con leucemia mieloide aguda (LMA) CD-33 positiva de novo no tratada previamente en Espa\u00f1a.<\/p>\n<p>El objetivo de la publicaci\u00f3n era evaluar la relaci\u00f3n coste-utilidad incremental (ICUR) de GO + SOC vs SOC solo para el tratamiento de pacientes con LMA CD-33 positiva de novo no tratada previamente, desde la perspectiva del Servicio de Salud Espa\u00f1ol.<\/p>\n<p>El art\u00edculo ha sido publicado en la revista\u00a0<em>ClinicoEconomics and Outcomes Research<\/em>, siendo los autores Mareque M, Montesinos P, Font P, Guinea JM, de la Fuente A, Soto J, Oyag\u00fcez I, Brockbank J, Iglesias T, Llinares J, Sierra J.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>De acuerdo con\u00a0los resultados presentados en el art\u00edculo:\u00a0Cost-effectiveness analysis of gemtuzumab ozogamicin for first-line treatment of patients with CD-33 positive acute myeloid leukaemia in Spain, el tratamiento con gemtuzumab ozogamicina (GO) + quimioterapia habitual (SOC)\u00a0podr\u00eda ser una opci\u00f3n m\u00e1s eficiente para el tratamiento en primera l\u00ednea en pacientes con leucemia mieloide aguda (LMA) CD-33 positiva&#8230; <\/p>\n<div class=\"clear\"><\/div>\n<p><a href=\"https:\/\/porib.com\/en\/tratamiento-para-leucemia-mieloide-aguda-mas-eficiente-para-el-sns\/\" class=\"excerpt-read-more\">Read More<i class=\"fa fa-caret-right icon-caret-right\"><\/i><\/a><\/p>\n","protected":false},"author":4,"featured_media":16093,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[67],"tags":[],"class_list":["post-16092","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ultimas-noticias"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/16092"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=16092"}],"version-history":[{"count":1,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/16092\/revisions"}],"predecessor-version":[{"id":16094,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/16092\/revisions\/16094"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media\/16093"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=16092"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=16092"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=16092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}